Stock search

Ticker or company name

Compare stocks

Market: US

  • CVSCVS Health
  • MCKMcKesson
  • SYKStryker Corporation

Add stock

Ticker or company

Summary

CVS
CVS Health
$88,59Down −0,85%
Year: Up +13%
83/100Best scoreRatio would consider buying
Open stock page
MCK
McKesson
$1 105,04Up +0,20%
Year: Up +30%
72/100Ratio would consider buying
Open stock page
SYK
Stryker Corporation
$310,72Up +0,35%
Year: Down −17%
72/100Ratio would consider buying
Open stock page

Verdict

CVS has the best score (83). MCK grows revenue the fastest. CVS is the cheapest by forward P/E. CVS has the lowest debt load. SYK has the highest net margin.

Verdict by our methodology based on current metrics. Not an investment recommendation.

Traffic light — 10 checks

CheckCVS6 ✓ 3 — 0 ✕MCK5 ✓ 3 — 1 ✕SYK5 ✓ 3 — 1 ✕
P/E vs its history10,427,333,0
P/E vs industry10,427,333,0
Forward P/E10,720,718,2
Revenue growth, YoY+6,7%+8,2%+7,9%
EPS growth, YoY+2 107,7%+21,2%+23,4%
Net margin2,6%1,1%13,8%
Net debt / EBITDA−0,80,41,8
Free cash flow$15,6 bn$7,11 bn$4,57 bn
Share count over a year+1,7%−6,2%−0,5%
Cash runwayn/anot neededn/anot neededn/anot needed

Metrics

Best WorstNo mark — in between

Metric · betterCVSTTMMCKTTMSYKTTMIndustry medianTTM
P/E TTM ↓Best: 10,427,3Worst: 33,025,1
Forward P/E ↓Best: 10,7Worst: 20,718,216,2
PEG ↓Best: 1,82,2Worst: 3,12,2
P/S TTM ↓Best: 0,30,3Worst: 4,52,2
EV/EBITDA ↓Best: 10,818,8Worst: 21,517,3
P/FCF ↓Best: 7,317,7Worst: 26,119,5

Price, %

  • CVSn/a
  • MCKn/a
  • SYKn/a

Returns

Best WorstNo mark — in between

PeriodCVSMCKSYK
1 yearn/an/an/a
3 yearsn/an/an/a
5 yearsn/an/an/a
All timen/an/an/a

“Per year” is the average annual return: 90% growth over 3 years is 23,9% per year, not 30%. “All time” starts at the IPO, so only “per year” compares fairly. Prices adjusted for splits, dividends reinvested.

Analysts and insiders

Best WorstNo mark — in between

CVSMCKSYK
Share of “buy”Best: 88%82%Worst: 77%
Beat the forecastBest: 4 of 4Best: 4 of 4Worst: 2 of 4
Average “surprise”Best: +22,0%+2,9%Worst: −2,5%
Insiders over 12 monthssales $322 msales $29,3 msales $580 m

Details are on each stock page.